KIF13B and colorectal carcinoma: MiR-1290 promotes the reprogramming of cancer cells by targeting kinesin family member 13B (KIF13B), which is involved in cytokinesis, the final step in cell division, that leads to nuclear re-fusion in cells, and aneuploidy, which is present in malignant tumors, including CRC [150].